Jin Yao

XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk

Xi Long, Yun Ma, Yun Feng Zhou et al. · BMC Cancer · 2009 · 59 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Biomarker analyses from the phase III CheckMate 214 trial of nivolumab plus ipilimumab (N+I) or sunitinib (S) in advanced renal cell carcinoma (aRCC).

Robert J. Motzer, Toni K. Choueiri, David F. McDermott et al. · Journal of Clinical Oncology · 2020 · 44 citations

Medicine, Oncology, Pharmacology +17

Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the <i>p</i>53 gene in hepatocellular carcinoma among guangxi population, China

Xi Long, Yun Ma, Hong Huang et al. · Molecular Carcinogenesis · 2007 · 41 citations

Medicine, Genetics, Molecular Genetics +11

Oral Interleukin-10 Alleviates Polyposis via Neutralization of Pathogenic T-Regulatory Cells

Allen Chung, Qingsheng Li, Sarah J Blair et al. · Cancer Research · 2014 · 34 citations · Full text

Life Sciences, Immunology, Pathology +17

Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer

Michelle S. Bousquet, Jiajia Ma, Ranjala Ratnayake et al. · ACS Chemical Biology · 2016 · 32 citations

Medicine, Molecular Biology, Oncology +17